31P‐MRS study of acetyl‐L‐carnitine treatment in geriatric depression: preliminary results
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Objective: This 12‐week study of two elderly, depressed subjects investigated the effect of acetyl‐L‐carnitine (ALCAR) treatment on the Hamilton Depression Rating Scale (HDRS) and on measures of high‐energy phosphate and membrane phospholipid metabolism. Methods: Two mildly depressed (HDRS 15–20), non‐demented male subjects 70 and 80 years old were compared with six non‐demented controls (all males, mean age of 73.6 ± 3.6 years). High‐energy and membrane phospholipid metabolites were measured by phosphorus magnetic resonance spectroscopic imaging (31 P MRSI) analysis. HDRS and 31 P MRSI measurements were taken at entry, 6 and 12 weeks for the depressed subjects. Results: 31 P MRSI analysis revealed elevated levels of phosphomonesters [PME(s – τ c)] in the prefrontal region of these mildly depressed subjects, which decreased with ALCAR treatment and showed a trend for correlation of the PME(s – τ c) levels with HDRS. ALCAR treatment also resulted in increasing levels of the prefrontal phosphocreatine (PCr), which correlated with HDRS. Conclusions: In the prefrontal region, the mildly depressed subjects compared with controls had elevated PME(s – τ c) levels which normalized after 12 weeks of ALCAR and increased PCr levels after ALCAR treatment. These preliminary findings suggest further studies are warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Carnitine—metabolism and functions
Bremer, J. (1983) · Physiological Reviews · doi:10.1152/physrev.1983.63.4.1420 · Cited by 1,666
Kato, T., Takahashi, S., Shioiri, T., & Inubushi, T. (1992) · Journal of Affective Disorders · doi:10.1016/0165-0327(92)90099-r · Cited by 205
Cited by
Acylcarnitines: Nomenclature, Biomarkers, Therapeutic Potential, Drug Targets, and Clinical Trials
Dambrova, M., Makrecka-Kuka, M., Kuka, J., Vilskersts, R., Nordberg, D., Attwood, M. M., Smesny, S., Sen, Z. D., Guo, A. C., Oler, E., et al. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000408 · Cited by 507
The role of mitochondria in mood disorders: from physiology to pathophysiology and to treatment
Giménez-Palomo, A., Dodd, S., Anmella, G., Carvalho, A. F., Scaini, G., Quevedo, J., Pacchiarotti, I., Vieta, E., & Berk, M. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.546801 · Cited by 140
Creatine monohydrate in resistant depression: A preliminary study
Roitman, S., Green, T., Osher, Y., Karni, N., & Levine, J. (2007) · Bipolar Disorders · doi:10.1111/j.1399-5618.2007.00532.x · Cited by 118
A review of current evidence for acetyl-l-carnitine in the treatment of depression
Wang, S.-M., Han, C., Lee, S.-J., Patkar, A. A., Masand, P. S., & Pae, C.-U. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2014.02.005 · Cited by 110
“Moreover, a preliminary study reported the efficacy of ALC in the treatment of geriatric depression through the normalization of phosphomonoester levels in the prefrontal regions (Pettegrew et al., 2002).”
BackgroundCreatine for the Treatment of Depression
Kious, B. M., Kondo, D. G., & Renshaw, P. F. (2019) · Biomolecules · doi:10.3390/biom9090406 · Cited by 74
Metadata
- Authors
- Pettegrew, J. W., Levine, J., Gershon, S., Stanley, J. A., Servan‐Schreiber, D., Panchalingam, K., & McClure, R. J.
- Venue
- Bipolar Disorders
- Publisher
- Wiley
- Published
- 2002-02
- Volume
- 4
- Issue
- 1
- Pages
- 61-66
- ISSN
- 1398-5647 (ISSN-L)
- 1399-5618
- OpenAlex
- W2082351311
- Cited by
- 81
- References
- 2
- FWCI
- 1.12
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: 31P‐MRS study of acetyl‐L‐carnitine treatment in geriatric depression: preliminary results. https://app.cochat.ai/papers/10.1034/j.1399-5618.2002.01180.x
- The paper
- Pettegrew, J. W., Levine, J., Gershon, S., Stanley, J. A., Servan‐Schreiber, D., Panchalingam, K., & McClure, R. J. (2002). 31P‐MRS study of acetyl‐L‐carnitine treatment in geriatric depression: preliminary results. Bipolar Disorders. https://doi.org/10.1034/j.1399-5618.2002.01180.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.